Intelligence · Patents
Patents expiring in 2029
Annual patent cliff calendar for 2029 — US pharmaceutical patents by expiration date.
- Patents
- 713
Quick answer
713 indexed pharmaceutical patents have expiration dates in 2029. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7632502
Cell wall mannoproteins and active epitopes from Candida albicans and antibodies recognizing them
granted -
US 7632847
Biphenyl compounds useful as muscarinic receptor antagonists
granted -
US 7635485
Method of accelerated vaccination against Ebola viruses
granted -
US 7635483
Streptococcal C5a peptidase vaccine
granted -
US 7635486
Recombinant lipidated PsaA protein, methods of preparation and use
granted -
US 7635683
Quinoxalinyl tripeptide hepatitis C virus inhibitors
granted -
US 7635712
Salinosporamides and methods for use thereof
granted -
US 7635688
Development of a preventive vaccine for filovirus infection in primates
granted -
US 7635474
VEGF-binding fusion proteins
granted -
US 7635476
Anti-hepatitis a virus antibodies
granted -
CA 2765866
FORMULATION PHARMACEUTIQUE
granted -
US 7638284
Immunoglobulin A inducing protein and uses therefor
granted -
US 7638269
Viral capsid assembly intermediates and methods of production
granted -
US 7638300
In vivo incorporation of unnatural amino acids
granted -
US 7638135
Collagen-binding proteins from enterococcal bacteria
granted -
US 7638145
Cultivated agarwood
granted -
US 7638130
Truncated recombinant major outer membrane protein antigen (R56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines
granted -
US 7638550
Pyrrolic derivatives with histone deacetylase inhibitory activity
granted -
US 7638134
Insertion sites in fowlpox vectors
granted -
US 7638494
G-type peptides to ameliorate atherosclerosis
granted -
US 7638501
Method of treatment of mitochondrial disorders
granted -
US 7638507
Compositions for treatment of inflammatory diseases
granted -
US 7638543
Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
granted -
US 7638678
Animal model for perimenopause and menopause and methods of inducing ovarian failure
granted -
US 7638624
Compositions and methods relating to novel benzodiazepine compounds and derivatives
granted -
US 7638639
Substituted pyrrolidine and related compounds
granted -
US 7638640
Purifications of pomegranate ellagitannins and their uses thereof
granted -
US 7638638
Dipeptidyl peptidase inhibitors
granted -
US 7638333
Anthrax vaccine
granted -
US 7638282
Genes of an otitis media isolate of nontypeable Haemophilus influenzae
granted -
US 7638283
Amyloid β protein (globular assembly and uses thereof)
granted -
US 7638544
Dimeric small molecule potentiators of apoptosis
granted -
US 2009326434
Anti-Microbial Photodynamic Therapy
granted -
US 7641906
Intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus influenzae or Moraxella catarrhalis
granted -
US 7641902
Compositions and methods for detecting cancer and for inhibiting metastasis
granted -
US 7641909
Avirulent, immunogenic flavivirus chimeras
granted -
US 7642275
Histone deacetylase inhibitors
granted -
US 7642234
Beta-2-glycoprotein 1 is an inhibitor of angiogenesis
granted -
US 7642355
Biphenyl compounds useful as muscarinic receptor antagonists
granted -
US 7642253
Histone deacetylase inhibitors
granted -
US 7642280
Inhibitors of acyl glucosaminyl inositol amidase and methods of use
granted
Frequently asked questions
How many pharma patents expire in 2029?
713 published patents in our USPTO index have expiration dates falling in calendar year 2029.